硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 SIRT3 抗体对
试剂盒

抗人 SIRT3 抗体对

01AB03392

Sirtuin 3 (SIRT3) is the primary NAD+-dependent deacetylase localized within the mitochondrial matrix, where it serves as a master regulator of metabolic fidelity and energy homeostasis. It features a conserved enzymatic core with a Rossmann fold that enables the deacetylation of diverse substrates involved in fatty acid oxidation, the TCA cycle, and the electron transport chain. Key partners include ACADM, OGDH, and GLUD1, as well as antioxidant enzymes like MnSOD2. By enhancing ATP production and mitochondrial biogenesis via PGC-1alpha, SIRT3 protects against oxidative stress and inhibits the opening of the mitochondrial permeability transition pore. Clinically, SIRT3 deficiency is linked to insulin resistance in skeletal muscle, cardiac hypertrophy, and acute kidney injury. Its ability to deacetylate FOXO3alpha and GSK3beta further supports its role in tissue protection, making it a critical target for research into metabolic and age-related diseases.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
SIRT3
基因别名
SIR2L3
蛋白别名
sirtuin 3; SIRT3
UniProt
Q9NTG7
物种
Human

产品详情

靶点名称
SIRT3
蛋白名称
sirtuin 3
蛋白别名
NAD-dependent protein deacetylase sirtuin-3; mitochondrial; hSIRT3; NAD-dependent protein delactylase sirtuin-3; Regulatory protein SIR2 homolog 3; SIR2-like protein 3
靶点基因名
SIRT3
基因别名
SIR2L3
UniProt
Q9NTG7
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Sirtuin 3 (SIRT3) is the primary NAD+-dependent deacetylase localized within the mitochondrial matrix, where it serves as a master regulator of metabolic fidelity and energy homeostasis. It features a conserved enzymatic core with a Rossmann fold that enables the deacetylation of diverse substrates involved in fatty acid oxidation, the TCA cycle, and the electron transport chain. Key partners include ACADM, OGDH, and GLUD1, as well as antioxidant enzymes like MnSOD2. By enhancing ATP production and mitochondrial biogenesis via PGC-1alpha, SIRT3 protects against oxidative stress and inhibits the opening of the mitochondrial permeability transition pore. Clinically, SIRT3 deficiency is linked to insulin resistance in skeletal muscle, cardiac hypertrophy, and acute kidney injury. Its ability to deacetylate FOXO3alpha and GSK3beta further supports its role in tissue protection, making it a critical target for research into metabolic and age-related diseases.